Hypogammaglobulinemia Observed One Year after Rituximab Treatment for Idiopathic Thrombocytopenic Purpura

Abstract EN

We present the case of a 19-year-old female with severe hypogammaglobulinemia after having had treatment with rituximab for idiopathic thrombocytopenic purpura requiring intravenous immunoglobulins.

She was admitted with the diagnosis of left-sided pneumonia with parapneumonic effusion.

The patient was treated with piperacillin/tazobactam after having a poor response to co-amoxiclav.

The patient had been tested for immunoglobulin levels, and the levels were very low.

She has a history of ITP for which she received steroids.

She also received rituximab for the same on four separate occasions, and the last one was about 1 year ago.